Search research articles
Contact Us
Filters
Showing results (141-150 of 164) with videos related to
Page
of 17
Sort By:
Investigative Radiology
|
November 30, 2012
Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model
April M Chow, Mingqian Tan, Darwin S Gao, et al.
Frontiers in Oncology
|
November 16, 2020
Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts
Peter Qiao, Nadia R Ayat, Amita Vaidya, et al.
Biomacromolecules
|
July 9, 2016
Influence of Molecular Structure on the In Vivo Performance of Flexible Rod Polyrotaxanes
Christopher J Collins, Yawo Mondjinou, Bradley Loren, et al.
Bioconjugate Chemistry
|
April 3, 2019
Extradomain-B Fibronectin-Targeted Dextran-Based Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Probe for Detecting Pancreatic Cancer
Zheng Han, Shuixing Zhang, Kenji Fujiwara, et al.
International Journal of Biomedical Imaging
|
May 29, 2018
Cryo-Imaging and Software Platform for Analysis of Molecular MR Imaging of Micrometastases
Mohammed Q Qutaish, Zhuxian Zhou, David Prabhu, et al.
Bioconjugate Chemistry
|
February 17, 2017
Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI
Zheng Han, Yajuan Li, Sarah Roelle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 16, 2019
Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles
Da Sun, Rebecca M Schur, Avery E Sears, et al.
Pharmaceutical Research
|
August 28, 2024
MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models
Victoria Laney, Ryan Hall, Xueer Yuan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 28, 2020
Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model
Da Sun, Wenyu Sun, Song-Qi Gao, et al.
Nucleic Acid Therapeutics
|
May 30, 2019
Formulation of Biocompatible Targeted ECO/siRNA Nanoparticles with Long-Term Stability for Clinical Translation of RNAi
Nadia R Ayat, Zhanhu Sun, Da Sun, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 164) with videos related to
Sort By:
Page
of 17
Investigative Radiology
|
November 30, 2012
Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model
April M Chow, Mingqian Tan, Darwin S Gao, et al.
Frontiers in Oncology
|
November 16, 2020
Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts
Peter Qiao, Nadia R Ayat, Amita Vaidya, et al.
Biomacromolecules
|
July 9, 2016
Influence of Molecular Structure on the In Vivo Performance of Flexible Rod Polyrotaxanes
Christopher J Collins, Yawo Mondjinou, Bradley Loren, et al.
Bioconjugate Chemistry
|
April 3, 2019
Extradomain-B Fibronectin-Targeted Dextran-Based Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Probe for Detecting Pancreatic Cancer
Zheng Han, Shuixing Zhang, Kenji Fujiwara, et al.
International Journal of Biomedical Imaging
|
May 29, 2018
Cryo-Imaging and Software Platform for Analysis of Molecular MR Imaging of Micrometastases
Mohammed Q Qutaish, Zhuxian Zhou, David Prabhu, et al.
Bioconjugate Chemistry
|
February 17, 2017
Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI
Zheng Han, Yajuan Li, Sarah Roelle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 16, 2019
Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles
Da Sun, Rebecca M Schur, Avery E Sears, et al.
Pharmaceutical Research
|
August 28, 2024
MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models
Victoria Laney, Ryan Hall, Xueer Yuan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 28, 2020
Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model
Da Sun, Wenyu Sun, Song-Qi Gao, et al.
Nucleic Acid Therapeutics
|
May 30, 2019
Formulation of Biocompatible Targeted ECO/siRNA Nanoparticles with Long-Term Stability for Clinical Translation of RNAi
Nadia R Ayat, Zhanhu Sun, Da Sun, et al.
Page
of 17